Cost-effectiveness analysis of escitalopram versus paroxetine in treatment of generalized anxiety disorder (GAD) in the United States
May 1, 2014, 00:00
10.1016/j.jval.2014.03.1265
https://www.valueinhealthjournal.com/article/S1098-3015(14)01316-3/fulltext
Title :
Cost-effectiveness analysis of escitalopram versus paroxetine in treatment of generalized anxiety disorder (GAD) in the United States
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)01316-3&doi=10.1016/j.jval.2014.03.1265
First page :
A216
Section Title :
Mental Health
Open access? :
No
Section Order :
727